arginyl-glycyl-aspartic acid has been researched along with Plasmacytoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byers-Ward, V; Cierniewski, C; D'Souza, SE; Haas, TA; McGrath, DE; Piotrowicz, RS; Plow, EF; Smith, JW; Soule, HR | 1 |
Hattori, H; Inoue, R; Katagiri, S; Kitani, T; Shibayama, H; Tagawa, S | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Plasmacytoma
Article | Year |
---|---|
Ligand and cation binding are dual functions of a discrete segment of the integrin beta 3 subunit: cation displacement is involved in ligand binding.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Blood Platelets; Cations; Humans; Hybridomas; Integrin beta3; Integrins; Kinetics; Ligands; Mass Spectrometry; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Plasmacytoma; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1994 |
Laminin and fibronectin promote the chemotaxis of human malignant plasma cell lines.
Topics: Antibodies, Monoclonal; Cell Adhesion; Cell Size; Chemotaxis; Fibronectins; Humans; Laminin; Neoplasm Proteins; Neoplastic Stem Cells; Oligopeptides; Plasma Cells; Plasmacytoma; Receptors, Fibronectin; Receptors, Laminin; Receptors, Very Late Antigen; Tumor Cells, Cultured | 1995 |